Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates

Ionis Pharmaceuticals (IONS) came out with a quarterly loss of $0.98 per share versus the Zacks Consensus Estimate of a loss of$ 1.10. This compares to loss of $0.87 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10.91%. A quarter ago, it was expected that this drug discovery and development company would post a loss of$ 0.78 per share when it actually produced a loss of $0.06, delivering a surprise of 92.31%.Over the last fo ...